Key Findings
The North America hormone replacement therapy market growth is predicted to progress at a CAGR of 7.47% during the forecast period, 2021-2028. The key market growth drivers are innovations for human growth hormone therapy and testosterone therapy and new drug developments.

Market Insights
Canada and the United States are assessed for the North America hormone replacement therapy market growth analysis. In Canada, Health Canada has approved HRT products for use to treat menopausal symptoms like night sweats, hot flashes, vaginal dryness, and prevent osteoporosis. According to an article, several women were prescribed estrogen with or without progestin HRT to treat menopause symptoms. The two main types of HRT are estrogen without progestin and combined estrogen and progestin.
Progestin is added for uterine cancer prevention in women who never had a hysterectomy. Also, the availability of HRT and the increasing elderly population are boosting the market growth. For instance, by the age of 80, 1 in 10 will be living in a nursing home. Furthermore, the growing R&D activities for hormone replacement products are improving their efficiency and quality. The rising consumer awareness and technological innovations like new gel-based formulations are further contributing to market growth.

Competitive Insights
Some of the prominent market players are Pfizer Inc, Viatris Inc (Mylan NV), Amgen, Novo Nordisk A/S, Abbott Laboratories, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments